Average Co-Inventor Count = 10.68
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Compugen Ltd. Corporation (13 from 60 patents)
13 patents:
1. 10098934 - Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
2. 9617336 - C10RF32 antibodies, and uses thereof for treatment of cancer
3. 9555087 - Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
4. 9428574 - Polypeptides and uses thereof for treatment of autoimmune disorders and infection
5. 9375466 - Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
6. 9107862 - Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
7. 8828940 - Method of treating an ischemia-reperfusion injury-related disorder by administering GPCR ligands
8. 8415455 - Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
9. 8349801 - Peptide ligands for G-protein coupled receptors
10. 7939634 - Polynucleotides encoding polypeptides and methods using same
11. 7884180 - Peptides which bind to G protein-coupled receptors
12. 7758862 - Hepatocyte growth factor receptor splice variants and methods of using same
13. 7678769 - Hepatocyte growth factor receptor splice variants and methods of using same